| I |
|
Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency
|
| Zucker M, Landau M, Salomon O, Kenet G, Bauduer F, Samama M, Conard J, Denninger H, Abu-Samra H, Berruyer M, Green D, Seligsohn U, Zivelin A |
| |
|
Identification and Characterization of Novel Members of the Calcium and Integrin Binding Protein Family
|
| Maddox KM, Blamey CJ, Naik UP |
| |
|
Identification and in vitro Characterization of TGN 255, a Novel Synthetic Intravenous Low Molecular Weight Direct Thrombin Inhibitor
|
| Chahwala S, Chander C |
| |
|
Identification and Molecular Characterization of a Novel Factor V A2 Domain Tyrosine Deletion Mutation in a Patient with Factor V Deficiency and Bleeding
|
| Jones CD, Negro F, Darnell K, Zehnder JL |
| |
|
Identification of CLEC-2 as a Novel Signalling Receptor for Rhodocytin in Platelets
|
| Suzuki-Inoue K, Garcia A, Eble JA, Fuller G, Pohlmann S, Zitzmann N, Inoue O, Gartner TK, Morita T, Ozaki Y, Watson SP |
| |
|
Identification of Coagulation Factor VIII A2 Domain Residues Forming the Binding Epitope for Low-Density Lipoprotein Receptor-Related Protein
|
| Sarafanov A, Makogonenko E, Radtke K-P, Pechik I, Khrenov A, Ananyeva N, Strickland D, Saenko E |
| |
|
Identification of collagen-Binding Region of Platelet Glycoprotein VI (GPVI): Studies Using GPVI/Killer Cell Inhibitory Receptor Chimeric Proteins
|
| Miura Y, Jung SM, Moroi M |
| |
|
Identification of Factor VIII Binding Sites for Very Low Density Lipoprotein Receptor
|
| Kouiavskaia D, Ruiz J, Strickland D, Saenko E |
| |
|
Identification of Gene Defects in Brazilian Patients with Types 2B, 2M and 3 of von Willebrand Disease
|
| Garcia AA, Silva W, Jr1 , Tavella MH, Araújo AG, Franco RF |
| |
|
Identification of Genes Regulated by Oxidised LDL Acting Through Scavenger Receptor CD36 in Transfected HEK293 Cells
|
| McDermott-Roe CJ, Collot S, Clutterbuck R, McGregor JL |
| |
|
Identification of Genetic Variations in Genes Comprised in Vitamin K-dependent g-Carboxylation System
|
| Kimura R, Kokubo Y, Miyashita K, Otsubo R, Nagatsuka K, Otsuki S, Okayama A, Minematsu K, Naritomi H, Honda S, Tomoike H, Miyata T |
| |
|
Identification of Heparin-Binding Region of Snake Venom VEGF (VEGF-F) and Its Blocking Effect on VEGF-A165
|
| Tokunaga Y, Yamazaki Y, Takani K, Morita T |
| |
|
Identification of New Secreted Proteins from Haementeria Depressa Leech Salivary Complexes by Transcriptomic and Proteomic Analysis
|
| Faria F, Ricci-da-Silva ME, Junqueira-de-Azevedo ILM, Konno K, Ho PL, Chudzinski-Tavassi AM |
| |
|
Identification of Regions in Low-Density Lipoprotein Receptor-Related Protein Responsible for Interaction with A2 and A1/A3-C1-C2 Portions of Coagulation Factor VIII
|
| Sarafanov A, Makogonenko E, Andersen O, Khrenov A, Mikhailenko I, Strickland D, Saenko E |
| |
|
Identification of the Multimerin 1 Binding Region within the C1 Domain of Factor V
|
| Jeimy SB, Quinn-Allen MA, Fuller N, Kane WH, Hayward CPM |
| |
|
Identification of the Presence of Polymorphic Sites within Exon 28 of the von Willebrand Factor Gene Using Fluorescent SSCP
|
| Phillips RL, Lavender FL, O'Shaughnessy DF |
| |
|
Identification of the Region of FXIIIA Responsible for Binding to the Alpha Chain of Fibrin(ogen)
|
| Adamson PJ, Smith KA, Dissanayake MP, Ariens RAS, Grant PJ, Philippou H |
| |
|
Identification of Thrombin Antibodies in Patients with Antiphospholipid Syndrome
|
| Miesbach W, Asmelash G, Putz B, Matthias T, Scharrer I |
| |
|
Identification of Thrombocyte Microparticles in Zebrafish Blood and Their Role in Hemostasis
|
|
| |
|
Identification of Two Novel Mutations in ADAMTS13 Gene in A Pregnant Patient with Congenital Thrombotic Thrombocytopenic Purpura
|
| Liu F, Jin J, Dong N, Bai X, Ruan C |
| |
|
Identifying Hemostatic Modifier Loci Ameliorating FVII-Insufficiency Using Phenotypic Differences between Strains
|
| Rosen ED, Xuei X, Liang Z, Schroeder V, Suckow M, Foroud T, Mooney S, Edenberg H |
| |
|
Identifying Novel Genetic Determinants of Hemostatic Balance
|
| Ginsburg D |
| |
|
Identifying the Bleeding Tendency in Patients with Hypo- and Dysfibrinogenemia
|
| Siegemund A, Siegemund T, Petros S, Meyer M |
| |
|
Identifying the Incidence of Heparin Induced Thrombocytopenia
|
| Smythe MA, Koerber JM |
| |
|
Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy
|
| Consiglio P, De Michele S, Calabrò G, Aiosa A, Di Maio C, Vitale G, De Michele R, Li Vigni M, Salvia M, Diquattro M, Menozzi I |
| |
|
Idiopathic Thrombocytopenic Purpura at Children and Opportunistic Infections
|
| Petrov V |
| |
|
IgE Mediated Anaphylaxis to Factor VIII
|
| Kadar JG, Schuster J, Hunzelmann N, Saint-Remy JM |
| |
|
IgM Anti-beta2 Glycoprotein I Antibody as Potential Risk Factor of Thrombosis in Patients with Lupus Anticoagulants
|
| Huh HJ, Chi HS, Ju MY, Yoo SJ, Jang SS, Park CJ |
| |
|
IL-10 Inhibits TF mRNA and the Surface Expression of TF in Platelets-monocytes Aggregates In Stimulated Whole Blood
|
| Christersson C, Siegbahn A |
| |
|
Imaging and Plaque Instability
|
| Schaar J |
| |
|
Imaging Experimental Pulmonary Embolism in Dogs Using 99mTc-Llabeled SZ51-F(ab)2
|
| Ji S, Bai X, Ruan C, Wang C |
| |
|
Imaging of Highly Organized Vitronectin-Vimentin Polymeric Complexes that Express on the Surface of Activated Platelets and Platelet Microparticles using Atomic Force Microscopy
|
| Leong HS, Bateman RM, van Eeden S, Jiao YK, Walinski H, Podor TJ |
| |
|
Immunate S/D – Results of a Phase III, Prospective, Multicenter Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Efficacy of Immunate Solvent Detergent in Previously Treated Patients with Severe or Moderately Severe Hemophilia A
|
| Klukowska A, Nemes L, Lissitchkov T, Dobaczewski G, Komrska V, Fischer R, Auerswald G, Engl W, Hiebinger C, Abbühl B |
| |
|
Immune Thrombocytopenic Purpura in Childhood – Clinical and Immunologigal Investigations
|
| Kenderova V, Kabakchieva R, Perenovska P, Kalev I |
| |
|
Immune Tolerance Induction with Highly Purified Plasma-Derived Factor VIII Containing Von Willebrand Factor in Hemophilia a Patients with High-Responding Inhibitors
|
| Orsini F, Rothschild C, Beurrier P, Faradji A, Durin-Assolant A, Fressinaud E, Tellier Z, Goudemand J, Polack B |
| |
|
Immune Tolerance to Factor IX inhibitor
|
| Pai KM, Chan AK, Laudenbach L, McCusker PJ, Rivard GE, Jardine L, Walker I |
| |
|
Immune Tolerance with FEIBA in a Severe Haemophiliac B with Inhibitor
|
| Meunier S, Guillet B, Dargaud Y, Lienhart A, Chamouard V, Alliaume N, Gerland V, Negrier C |
| |
|
Immunodepletion of GPVI from Human Platelets Circulating in NOD/SCID Mice: Development of a Novel Animal Model for Evaluating the Therapeutic Efficacy of Compounds that Affect Human Platelet Function and Survival
|
| Boylan B, Wilcox DA, Newman DK, Kahn ML, Newman PJ |
| |
|
Immunohistochemical Localization of Protein Z (ZP) and Protein Z-Dependent Protease Inhibitor (ZPI) in Situ in Human Malignant Tumors
|
| Sierko E, Tokajuk P, Ramlau R, Zimnoch L, Kisiel W, Broze Jr GJ, Jr, Wojtukiewicz MZ |
| |
|
Immunomodulation of Transgene Responses Following Naked DNA Transfer of FVIII into Hemophilia A Mice
|
| Ye P-Q, Rawlings DJ, Thompson AR, Ochs HD, Miao CH |
| |
|
Immunotolerance Induction (ITI) with High Purity FVIII/VWF Concentrates in Inhibitors Patients with a High Risk of a Poor Response to ITI: A Prospective Surveillance
|
| Gringeri A, Musso R, Bernasconi S, Villar A, Brito D, Coppola A, Piseddu G, Prieto M, Santagostino E, Schiavoni M, Schinco PC |
| |
|
Impact of Different Thromboplastins on the International Normalized Ratio and MELD Score in Patients with Cirrhosis Listed for Liver Transplantation
|
| Cerrato G, Ruf A, Chavez L, Yantorno S, Andriani O, Podesta L, Villamil F, Forastiero R, Martinuzzo M |
| |
|
Impact of the First Trimester of Hormone Replacement Therapy on the Levels of Hypercoagulability Markers
|
| Guimarães DAM, Cardoso JE, Dusse LMS, Vieira LM, Franco RM, Franco HA, Alvim TC, Teixeira GS, Carvalho MG, Fernandes AP |
| |
|
Impaired ASA-Mediated Formation of Thromboxane in Cholesterol-Depleted Blood Platelets
|
| Boncler M, Watala C |
| |
|
Impaired Bradykinin Response to Ischemia and Exercise in Patients with Mild Congestive Heart Failure During Angiotensin-Converting Enzyme Treatment. Relationships with Endothelial Function, Coagulation and Inflammation
|
| Cugno M, Agostoni P, Mari D, Meroni PL, Gregorini L, Bussotti M, Anguissola GB, Donatelli F, Nussberger J |
| |
|
Impaired Healing of Cutaneous Wounds in Factor XIII-Deficient Mice
|
| Inbal A, Lubetsky A, Krapp T, Castel D, Shaish A, Dickneitte G, Modis L, Muszbek L, Inbal A |
| |
|
Impaired Insulin Signaling in Platelets from Patients with Diabetes Mellitus Type 2
|
| Andrade Ferreira I, Mocking AIM, Gorter G, van Haeften T, Akkerman JWN |
| |
|
Impaired Platelet Adhesion on Collagen Surfaces and Secretion Defect in Duchenne Muscular Dystrophy Patients
|
| Labarque V, Goemans N, Freson K, Hoylaerts MF, Van Geet C |
| |
|
Impaired Thrombus Formation after Sterile Inflammation Induced by Endotoxin in a Murine Carotid Artery Thrombosis Model
|
| De Kruif MD, Hansen H, Keller TT, van der Wal AC, Spek CA, Reitsma PH, ten Cate H |
| |
|
Implantation of Total Hip Prosthesis in a Hemophilic Patient – Is Antithrombotyc Prophylaxis Necessary?
|
| Stankovic S, Siljanovski N, Hristov D, Kamnar J, Stojanovic A |
| |
|
Implementation of a Telematic Homecare Platform for Oral anticoagulant Management
|
| Williams K, Gardiner C, Mackie IJ, Machin SJ, Cohen H |
| |
|
Implication of Local Versus Independent Assessment of Reference Test for Accuracy of a Rapid Point-of Care Quantitative Assay for D-dimer (Cardiac D-dimer) in the Diagnosis of Deep Vein Thrombosis
|
| Huisman MV, Dempfle CE, Prins MH, Korte W |
| |
|
Importance of Pre-Analytical Variables in the Measurement of Platelet-Derived Microparticles
|
| Ahmad S, Amirkhosravi A, Langer F, Desai H, Amaya M, Francis JL |
| |
|
Importance of Temporal Flow Gradients and Integrin aIIbb3 Mechanotransduction for Shear-Activation of Platelets
|
| Yuping Y, Isaac G, Warwick S, Nesbitt XX, Shaun PJ |
| |
|
Importance of the FV Level Screening for Individual Thrombotic Risk
|
| Kostka H, Schellong S, Kuhlisch E, Gehrisch G, Siegert G |
| |
|
Improved Oral Anticoagulant Therapy Monitoring by Eliminating ISI and MNPT from INR Determinations
|
| Carroll WE, Jackson RD, Taylor M, Dlott J |
| |
|
Improvement of STA: STACLOT APC-R Test for the Detection of Factor V Leiden by Using APCR Ratio
|
| Coen Herak D, Milos M, Zadro R |
| |
|
In Patients with the Biphasic Waveform, Lipoprotein Complexation Does Not Retard C-Reactive Protein Induced Complement Activation
|
| Marshall NJ, Downey C, Hirschfield G, Toh CH |
| |
|
In Silico Design and in Vitro Validation of a Mimotope for Blocking a FVIII-inhibitor Antibody ESH8
|
| Zabe-KühnM , Hoffmann D, Hohm T, Albert T, Schwaab R |
| |
|
In Type 2 Diabetes, P-Selectin- But Not CD63 -Exposing Microparticles Are Elevated in the Postprandial State
|
| Tushuizen ME, Nieuwland R, Snoeck DP, Boerop J, Rustemeijer C, Sturk A, Heine RJ, Diamant M |
| |
|
In Vitro Stability of Dilutions of the Recombinant Factor VIII Kogenate FS for Continuous Infusion Use
|
| Rand ML, Schmugge M, Clark D, Lillicrap D, Blanchette VS |
| |
|
Inactivation of Factor V during Sepsis-Induced Disseminated Intravascular Coagulation: Reconciliation of Total Factor V Activity with Its Cleavage and Inactivation as Assessed by SDS-PAGE and Immunoblotting
|
| Samis JA, Stewart KA, Toh CH, Downey C, Neshiem ME |
| |
|
Inactivation of the Human Platelet cGMP-Induced cAMP Phosphodiesterase (PDE3A) by Affinity Labeling of an Octapeptide in the Unique 44 Amino Acid Flexible Loop
|
| Hung SH, Kim CH, Barnes KD, Zhang W, Colman RF, Colman RW |
| |
|
Inappropriateness of Diagnostic Management in Patients with Suspected Pulmonary Embolism: Frequency, Predictors and Association with Outcome
|
| Roy PM, Meyer G, Vielle B, Le Gall C, Verschuren F, Furber A |
| |
|
Incidence of Deep Vein Thrombosis after Knee Arthroscopy without Thromboprophylaxis
|
| Hoppener MR, Ettema HB, Henny ChP, Verheyen CCPM, Büller HR |
| |
|
Incidence of Deep Vein Thrombosis Following Gynecologic Laparoscopy: A Prospective Cohort Study
|
| Ageno W, Manfredi E, Ghezzi F, Dentali F, Squizzato A, Crotti S, Serati M, Steidl L, Bolis PF, Venco A |
| |
|
Incidence of Factor VIII Inhibitor in Hemophilia ‘A’ in Ceara – Brazil
|
| Holanda RARR, Silva HF, Neto GCG, Sobreira ACM, Silva MAM |
| |
|
Incidence of Major Bleeding in a Large Paediatric Cohort of Patients Requiring Warfarin Therapy
|
| Newall F, Campbell J, Savoia H, Barnes C, Monagle P |
| |
|
Incidence of Venous and Arterial Thromboembolism in Asymptomatic Carriers of the Prothrombin 20210A Mutation – A Prospective Cohort Study
|
| Coppens M, Van der Poel MHW, Hamulyák K, Van der Meer J, Veeger NJ, Prins MH, Büller HR, Middeldorp S |
| |
|
Incidence of Venous Thromboembolism Among Dutch Airline Pilots
|
| Kuipers S, Schreijer AJM, Cannegieter SC, Middeldorp S, Büller HR, Rosendaal FR |
| |
|
Incomplete P2Y12 Receptor Blockade by Clopidogrel Is Not Due to the Presence of an Internal Pool of P2Y12 Receptors
|
| Judge HM, Buckland RJ, Storey RF |
| |
|
Incorporation of a Comprehensive Pediatric Thrombosis Program as Part of the Multidisciplinary Care Team for Children with Congenital Heart Disease: A Prospective Cohort Study
|
| Massicotte M, Rebeyka I, Dyck J, Conradi A, Bauman M, Mitchell L |
| |
|
Increase of Protein C Activity at Nephrotic Syndrome in Children
|
| Panyutina Y, Kabilyanskaya V |
| |
|
Increased Adhesion of Erythrocytes from Patients with Polycythemia Vera Is Mediated by Lu/B-CAM
|
| Wautier M-P, Gane P, El Nemer W, Rain J-D, Le Van Kim C, Wautier J-L |
| |
|
Increased Aspirin Hydrolysis in Plasma of Patients with Type 2 Diabetes Mellitus: A New Mechanism of ‘Aspirin Resistance’?
|
| Gres[scaron]ner P, Bryszewska M, Waczulíková I, [Scaron]ikurová L, Watala C |
| |
|
Increased Circulating Endothelial Cells in Acute Congestive Heart Failure: Comparison with von Willebrand Factor and Soluble E Selectin
|
| Chong AY, Lip GYH, Freestone B, Blann AD |
| |
|
Increased Coagulation Activation in Persons with Echogenic Carotid Plaques
|
| Notø ATW, Mathiesen EB, Amiral J, Hansen JB |
| |
|
Increased Fibrinolytic Activity in Patients with a More Severe Clinical Phenotype of Severe Hemophilia A
|
| Van Dijk K, Van der Bom JG, Fischer K, Lisman T, de Groot PhG, Van den Berg HM |
| |
|
Increased Formation of Platelet-derived Microparticles by Heparin
|
| Michelsen AE, Brodin E, Brosstad F, Hansen JB |
| |
|
Increased Haemostasis Potential Persists in Young Patients with Previous Ischemic Cerebrovascular Event
|
| Antovic A, Anzej S, Peternel P, Stegnar M |
| |
|
Increased Levels of Hepatocyte Growth Factor in Patients with DIC
|
| Kawasugi K, Fukuda A, Shimazu C, Noguchi M, Tashiro H, Gotoh M, Shirafuji N, Matuda J, Miyazawa Y |
| |
|
Increased Levels of Procoagulant Factors Associated with Increased Potential for Thrombin Generation in Patients with Premature Myocardial Infarction
|
| Wright JR, Thompson J, Singh RK, Brouilette S, Pasi J, Samani NJ, Goodall AH |
| |
|
Increased outside-in Signaling and Adhesive Functions under Shear Conditions of Cells Expressing the aIIbb3T562N Integrin
|
| Legendre P, Salsmann A, Rayes J, Trassard O, Kieffer N, Baruch D |
| |
|
Increased Plasma and Platelet Surface Fibronectin in Acute Myocardial Infarction Patients
|
| Wu J, Li Q, Zhai Z, Han Y, Xu X, Li Q, Ni H |
| |
|
Increased Plasma Levels of Lipoprotein(a) Correlate with Severity of Angiographically Defined Coronary Artery Disease
|
| Lima LM, Carvalho MG, Vale AAL, Mota APL, Fonseca Neto CP, Garcia JCF, Saad JA, Fernandes AP, Sousa MO |
| |
|
Increased Platelet Activation in Cystic Fibrosis: A Role for cAMP/Adenylate Cyclase But Not for Mead Acid or Platelet CFTR
|
| Linden MD, O'Sullivan BP, Frelinger III, AL1 , Barnard MR, Spencer-Manzon M, Laposata M, Michelson AD |
| |
|
Increased Platelet CD36 Antigen: A Useful Marker of Myeloproliferative Disorders. Parallel Evolution to That of BCR-abelson Transcript in Chronic Myeloid Leukaemia
|
| Bellucci S, Boval B, Chaouki M, Rain JD, Rousselot P |
| |
|
Increased Risk of Recurrent Venous Thromboembolism in Patients with Deep-Vein Thrombosis Who Are Carriers of the Factor V Leiden or Prothrombin Gene Mutation. A Meta-Analysis
|
| Marchiori A, Prins MH, Lensing AWA, Simioni P, Tormene D, Mosena L, Prandoni P |
| |
|
Increased Risk of Venous Thrombosis after Orthopedic and General Surgery. Results of the MEGA Study
|
| Bannink L, Doggen CJM, Nelissen RGHH, Rosendaal FR |
| |
|
Increased Sensitivity for Measurement of Factor VIII Using ROTEG and FVIII-/- Mouse Blood Supplemented with rFVIII
|
| Landskroner K, Olson NC, Jesmok G |
| |
|
Independent QA Exercise to Validate INR Test Strip Performance and Evaluate Perceptions of Excess Test Strip Error Messages in Support of the THINRS Trial
|
| Ruybalid L, Edson B, Vertrees J, Gunneman T, Howe B, Webster S, Jacobson A |
| |
|
Independent Qa Exercise to Validate Poc Coagulometer Reliability in Support of the Thinrs Trial and to Allay Perceptions of Possible Coagulometer Dysfunction
|
| Ruybalid L, Edson B, Vertrees J, Gunneman T, Howe B, Webster S, Jacobson A |
| |
|
Independent Regulation of Platelet p38 MAP Kinase by the Collagen Receptor a2b1
|
| Pavithra S, Pia R-MS, Loraine F, Richard WF |
| |
|
Individual Efficacy Measurement of FVIII Replacement Therapy in Cell-based Monitoring Tests
|
| Scholz T, Bassus S, Wegert W, Krause M, Escuriola-Ettinghausen C, Siegemund A, Scharrer I, Kreuz W, Engelmann L, Kirchmaier CM |
| |
|
Individual Replacement Therapy (IRT) with C1-Inhibitor Concentrate in Patients with Severe Hereditary Angioedema Increases Significantly Quality of Life Parameters Compared to Danazol Prophylaxis
|
| Kreuz W, Martinez-Saguer I, Aygoren-Pursun E, Rusicke E, Klingebiel T |
| |
|
Individual Time within Target Range (ITTR), an Accurate Predictor of Clinical Outcome in Patients with Acute Myocardial Infarction (AMI) Treated with Vitamin K Antagonists
|
| Veeger NJGM, Hillege HL, Piersma-Wichers M, van der Meer J |
| |
|
Individual Variation of Platelet Functions after in vitro Incubation with Aspirin: Assessment of Aspirin Resistance in Healthy Subjects Using PFA-100®
|
| Takahashi S, Iwashita M, Komine R, Shimizu A, Uchida T, Ishihara H, Shibano T, Watanabe G, Ikeda Y, Murata M |
| |
|
Induction of Immune Tolerance Utilizing Third Generation Recombinant Factor VIII [Advate]: A Report of Two Cases
|
| Recht M, Shapiro A |
| |
|
Induction of Renal PAI-1 Gene Expression in a Rat Model of Type-2 Diabetic Nephropathy and Role of Albumin in PAI-1 Induction
|
| Seki T, Hagiwara H, Yanagi M, Ariga T |
| |
|
Induction of Tolerance by Gene Therapy with B-cells Expressing Ig Fusion Proteins: Pre-clinical Success in Naïve and Immune Hemophilia A Mice
|
| Scott DW, Lei TC |
| |
|
Induction of Tolerance to b2Glycoprotein I in Mice
|
| Bettis B, Vega-Ostertag ME, Liu X, Gharavi AE, Pierangeli S |
| |
|
Inflammation and Coagulation in Two Models of Endotoxemia in Resistant and Sensitive Mice: Low Relevance of Activation of Coagulation in the Outcome
|
| Hernández-Espinosa D, Corral J, Yélamos J, Monreal Y, Mota R, Arcas I, Miñano A, Parrilla P, Vicente V |
| |
|
Inflammation and Venous Thromboembolism in Hospitalized Medical Patients
|
| Usman J, Young M, Brophy M, Lew R, Fiore |
| |
|
Inflammation, Disease Activity Indices and Hemostatic Markers in Patients with Systemic Lupus Erythematosus
|
| Arshinov AV, Masina IV |
| |
|
Inflammatory Markers are Associated with the Abdominal Aortic Diameter
|
| Miniati B, Macchi C, Marcucci R, Gori AM, Conti AA, Corsi AM, Bandinelli S, Ferrucci L, Abbate R, Gensini GF |
| |
|
Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects
|
| Morange PE, Le Cam-Duchez V, Aillaud MF, Juhan-Vague I, Saladin-Théron C, Borg JY, Bauters A, Jude B, Pernod G, Polack B, De Prost D, Vergnes C, Vollot F, Dutrillaux F, Lorenzini JL, Schved JF, Lequerrec A, Boinot C, Freyburger G, Biron-Andréani C |
| |
|
Influence of ABO Blood Group on the Collagen-Binding Assay
|
| Garcia AA, Baggio MS, Oliveira LCO, Franco RF |
| |
|
Influence of Cinnamic Acid on the Expression of Tissue Factor Induced by Tumor Necrosis Factor a and Its Mechanism in Vascular Endothelial Cells
|
| Li XF, Wen ZB, He XF, He SL |
| |
|
Influence of Factor IIa- and Factor Xa-Inhibitors on Thrombin Generation in Platelet-Rich Plasma
|
| Siegemund T, Siegemund A, Petros S, Scholz U, Engelmann L |
| |
|
Influence of Factor V Leiden and Lupus Anticoagulant on a New Venom-Based Clotting Assay of Protein C
|
| Cooper PC, Cooper SM, Goodfellow KJ, Kitchen S, Makris M |
| |
|
Influence of Factor XI Activation by Thrombin on Coagulation Kinetics: A Mathematical Model
|
| Druzhinin AV, Khanin MA |
| |
|
Influence of Fondaparinux on INR Expression in Patients Receiving Oral Vitamin K Antagonists
|
| Flaujac C, Elalamy I, Horellou MH, Conard J, Samama MM |
| |
|
Influence of Gender, Age, and Oral Contraception on Hemostatic Parameters Determined by Rotation Thrombelastography
|
| Sucker C, Tharra K, Zotz RB, Scharf RE |
| |
|
Influence of Interleukins on CD 4+ T-lymphocyte Adhesion to Extracellular Matrix in Presence of Platelets under Flow Condition
|
| Solpov DA, Vitkovsky Y, Shenkman B, Kuznik B |
| |
|
Influence of Platelet Transfusion on Thrombin Generation in Patients with Bone Marrow Transplantation
|
| Siegemund T, Siegemund A, Scholz U, Petros S, Lange T, Engelmann L, Niederwieser D |
| |
|
Influence of Polymorphisms in the Endothelial Protein C Receptor Gene on the Risk of Venous Thromboembolism in Carriers of the Factor V Leiden Mutation
|
| Medina P, Navarro S, Estellés A, Vayá A, Villa P, Mira Y, Ferrando F, Bertina RM, Aznar J, España F |
| |
|
Influence of Pre Donation Donor Factors on the Yield of Platelets Using Intermittent Flow Cell Separators
|
| Chaudhary RK, Das SS, Shukla JS |
| |
|
Influence of Streptokinase on the Fibrinolytic System Components in vivo
|
| Krasnobryzha I, Savchuk O |
| |
|
Influence of Tetramethylpyrazine on the Expression of Tissue Factor Induced by IL-6 in Vascular Endothelial Cells
|
| Wen ZB, He XF, Xiong SL, He SL |
| |
|
Influence of the Enos Gene Polymorphisms on the Homocysteine Plasma Levels in Healthy Subjects
|
| Sofi F, Fatini C, Sticchi E, Gori AM, Filoni C, Baldi M, Casini A, Surrenti C, Gensini GF, Abbate R |
| |
|
Influence of the Tissue Factor Pathway on Initiation of Warfarin Anticoagulant Therapy
|
| Needham J, Taylor J, Mainwaring J, Blann A, Morrissey J, McLellan D |
| |
|
Influence of Type of Factor VIII Gene Mutation on Inhibitor Development in a Single Centre Cohort of Severe Haemophilia a Patients
|
| Gouw SC, Van der Bom JG, Van Dijk K, Mauser-Bunschoten EP, Ploos van Amstel JK, Van den Berg HM |
| |
|
Inherited and Acquired Thrombophilic Risk Factors in Atherosclerotic Disease
|
| Marcucci R, Sofi F, Gori AM, Coppo M, Comeglio M, Lombardi A, Margheri M, Prisco D, Abbate R, Gensini GF |
| |
|
Inherited Bleeding Disorders: The Emilia-Romagna Region Register, 2004 Update
|
| Tagliaferri A, Pattacini C, Rivolta GF, Albertini P, Arbasi C, Biasoli CD'IncàM, Marietta M, Moratelli S, Rodorigo G, Vincenzi D |
| |
|
Inherited Mucocutaneous Bleeding: Clinical Assessment, Relative Frequency of Diseases and High Prevalence of Bleeders with Normal Laboratory Tests: Prospective Study of 280 Patients and 299 Non Bleeder Controls
|
| Quiroga T, Goycoolea M, Muñoz B, Morales M, Aranda E, Martínez C, Panes O, Pereira J, Mezzano D |
| |
|
Inherited Thrombophilia (IT) in Patients with Chronic Venous Ulceration (CVU)
|
| Wiszniewski A, Windyga J, Bykowska K, Meissner AJ |
| |
|
Inherited Thrombophilias in the Patients with Prosthetic Heart Valves
|
| Vavilova T, Sirotkina O, Kadinskaya M, Orlovskiy P, Emanuel V |
| |
|
Inhibition Kinetics of Plasmin-staphylokinase (Pm-STA) and Plasmin-Streptokinase (Pm-SK) Complexes with Different Protein Inhibitors
|
| Levashov MY, Aisina RB, Varfolomeyev SD |
| |
|
Inhibition of 5-Hydroxytriptamine2A (5-HT2A) Receptor Prevents Occlusive Thrombus Formation on Neointima of Rabbit Femoral Artery
|
| Nishihira K, Yamashita A, Tanaka N, Kawamoto R, Imamura T, Yamamoto R, Eto T, Asada Y |
| |
|
Inhibition of Arterial Thrombosis by a Small Molecule FVIIa Inhibitor, Heparin, and Enoxaparin
|
|
| |
|
Inhibition of Catalytic Activity of Plasmin by Recombinant Human Prion Protein
|
| Larisa C, Evgen M, Evgueni S |
| |
|
Inhibition of Coagulation Cascade Enzymes by a Covalent Antithrombin-Heparin Complex
|
| Patel S, Berry LR, Chan AKC |
| |
|
Inhibition of Collagen-Induced Thrombus Formation by Insulin Is Absent in Diabetes Mellitus Type 2
|
| Andrade Ferreira I, Mocking AIM, Feijge MAH, Gorter G, van Haeften T, Heemskerk JW, Akkerman JWN |
| |
|
Inhibition of Microparticle Release from Endothelial Cells Induces Apoptosis
|
| Abid Hussein MN, Sturk A, Hau RCM, Evers LM, Nieuwland R |
| |
|
Inhibition of Monocyte-induced Procoagulant Activation with Antithrombin
|
| Sturn D, Kaneider NC, Mosheimer BA, Patsch JR, Wiedermann CJ |
| |
|
Inhibition of Platelet Activation in Diabetic Rats by Chronic Treatment with the Guanylyl Cyclase Activator HMR1766
|
| Schäfer A, Flierl U, Vogt C, Hemberger M, Eigenthaler M, Walter U, Ertl G, Bauersachs J |
| |
|
Inhibition of Platelet Activation in Rats with Severe Congestive Heart Failure by Treatment with an Endothelial NO-Synthase Enhancer
|
| Schäfer A, Fraccarollo D, Widder J, Eigenthaler M, Walter U, Ertl G, Bauersachs J |
| |
|
Inhibition of Platelet Glycoprotein Ib (GP Ib) by a Monoclonal Antibody Prevents Platelet Dependent Thrombosis in Mice
|
| Perzborn E, Arndt B, Bergmeier W, Nieswandt B |
| |
|
Inhibition of Protein Kinase C Results in an Altered Thrombus Phenotype with Suppressed Platelet Aggregation and Increased Platelet Procoagulant Activity
|
| Strehl A, Munnix ICA, Kuijper,s MJE, Nieswandt B, Heemskerk JWM |
| |
|
Inhibition of the Catalytic Domain of Factor XIa (FXIac) by the Kunitz Protease Inhibitory Domain of Protease Nexin 2 (PN2KPI) Is Mediated by Interactions Between Lys192 of FXIac and Pro13 of PN2KPI and Between Tyr5901 of FXIac and Arg20 of PN2KPI
|
| Miller TN, Navaneetham D, Walsh PN |
| |
|
Inhibition of the Renin-Angiotensin System Does Not Reduce Platelet Activity at Rest or during Stress in Essential Hypertension
|
| Schwieler JH, Wallén NH, Kahan T, Nussberger J, Daleskog M, Johansson M-C, Hjemdahl P |
| |
|
Inhibition of the Renin-Angiotensin System Modulates the Procoagulant/Fibrinolytic Potential of Human Breast Carcinoma Cells
|
| Donati MB, Napoleone E, Di Santo A, Amore C, Martelli M, Lorenzet R |
| |
|
Inhibition of the Transcription Factor EGR-1 Significantly Reduces Neointima Formation in a Rabbit Iliac Artery Angioplasty Model
|
| Breuss JM, Cejna M, Olcaydu D, Bergmeister H, Brunner P, Losert U, Lammer J, Binder BR |
| |
|
Inhibition of thrombin generation by Otamixaban (XRP0673), a direct and selective factor Xa inhibitor
|
| Lorenz M, Stamm S, Hinder M, Laux V |
| |
|
Inhibition of Thrombin Generation by Warfarin
|
| Harenberg J, Fenyvesi T, Träger I, Hagedorn A, Giese, Ch, Weiss, Ch |
| |
|
Inhibition of Thrombosis after Vascular Injury with a Novel Tissue Factor-Targeted Thrombomodulin Fusion Protein
|
| Abendschein D, Wang Y-X, Light D, Hoefelmann C, Citkowicz A, Riffel A, McLean K |
| |
|
Inhibition of Tissue Factor Mediated Protease Activation by Mucosopolysaccharide Polysulfate. Results from Studies on Proteinchip Array Using SELDI-MS
|
| Fareed J, Florian-Kujawski M, Hoppensteadt D, Maddineni J, Chyna B, Raake W |
| |
|
Inhibition of Tissue Factor Procoagulant Activity by GRP78/BiP, an Endoplasmic Reticulum Chaperone
|
| Watson LM, Sood SK, Austin RC |
| |
|
Inhibitor Development and Treatment in Children
|
| Ljung RCR |
| |
|
Inhibitor Development in Previously Untreated or Minimally Treated Patients with Hemophilia a Treated with a Plasma-derived Solvent-detergent Factor VIII Concentrate
|
| Mara SM, Alessandro G, Giuseppe T, Antonio FS |
| |
|
Inhibitor Development in PTP's: A Retrospective Study in Germany
|
| von Auer C, Oldenburg J, Krause M, Miesbach W, Scharrer I |
| |
|
Inhibitory Effect of Luteolin on the PDGF-Induced Proliferation of Rat Aortic Vascular Smooth Muscle Cells
|
| Yun YP, Kim JH, Cho MR, Lim Y, Jin YR, Hong JT, Yoo HS |
| |
|
Inhibitory Effects of Andrographolide on LPS-Induced Tissue Factor Expression in Human Monocytic THP-1 Cells
|
| Lee YM, Hsiao G, Yen MH |
| |
|
Inhibitory Effects of Tirofiban on Platelet Function in Korean Patients During Percutaneous Coronary Intervention
|
| Han J, Park T, Park E, Kim H, Kim M |
| |
|
Initial Data on the Effects of Long-term Cigarette Mainstream Smoke Exposure and High Fat Diet in Apolipoprotein E-deficient Mice
|
| Lebrun S, Stinn W, Weiler H, Kuhl P, Friedrichs B, Urban H-J, von Holt K, Wallerath T, Schleef R |
| |
|
Initial Outpatient Treatment of Venous Thromboembolism with Fondaparinux (Arixtra®): The MATISSE trials
|
| Büller H |
| |
|
Initial Treatment of Patients with Acute Deep-Vein Thrombosis Using 8.000 IU Bid Low-Molecular-Weight Heparin Certoparin – A 24 Months Follow Up
|
| Harenberg J, Riess H, Fischer H, Brom J, Eidinger GW |
| |
|
Initiation of a Registry for Patients with Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
|
| Kremer HovingaLämmle JAB |
| |
|
Injury-Inducible Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and Perturbing Cyclin D1-Cdk4-p21WAF1/Cip1 Assembly
|
| Santiago FS, Ishii H, de Mestre A, Shafi S, Khurana R, Kanellakis P, Hulett MD, Bobik A, Martin JF, Chesterman CN, Zachary IC, Khachigian LM |
| |
|
INR Determination by Plasma-Based Methods Versus Point-of-Care Instruments in Patients with Antiphospholipid Antibody Syndrome on Anticoagulants
|
|
| |
|
INR Results of the CoaguChek® PT Test Compare Well with INR Results of International Reference Thromboplastins
|
| Plesch W, Jünschke A, Herbel P, Schulz I, Newhart A, Kitchen S, Kitchen DP, Mclean R, Dikkeschei B, van den Besselaar AMHP |
| |
|
Insensitivity of Thrombin Potential to Activated Protein C Due to Antibody-Mediated Qualitative or Quantitative Protein S Deficiencies
|
| Regnault V, de Moerloose P, Rivalan J, Pommereuil M, Wahl D, de Groot PG, Lecompte T |
| |
|
Insights from Structure/Function Analysis of Recombinant Fibrinogens
|
| Lord ST |
| |
|
Insulin Resistance and Platelet Activation in Obese Women
|
| Santilli F, Basili S, Pacini G, Guagnano MT, Manigrasso MR, Taraborelli T, Ciabattoni G, Patrono C, Davì G |
| |
|
Integrin a2b1 and Glycoprotein VI Dependent Calcium Signals in Platelets Interacting with Acid-Soluble Type I Collagen Under Flow
|
| Mazzucato M, Cozzi MR, Battiston M, Jandrot-Perrus M, Ruggeri ZM, De Marco L |
| |
|
Integrin As Scaffold
|
| Shattil SJ, Arias-Salgado EG, Buensuceso C, Soriani A, Moran B, Kasirer-Friede A |
| |
|
Integrins Mediate Shedding of Procoagulant Microparticles at Minimal Platelet Activation
|
| Cauwenberghs S, Feijge MAH, Keuren JFW, van Pampus ECM, Curvers J, Heemskerk JWM |
| |
|
Interaction between Paracetamol and Warfarin: A Double-Blind Placebo-Controlled Randomised Study
|
| Mahé I, Bertrand N, Drouet L, Simoneau G, Bal dit Sollier C, Mazoyer E, Caulin C, Bergmann JF |
| |
|
Interaction of BAY 59-7939 – A Novel, Oral, Direct Factor Xa Inhibitor – with Antiplatelet Agents: Monitoring and Therapeutic Applications
|
| Hoppensteadt D, Neville B, Schultz C, Cunanan J, Duff R, Perzborn E, Misselwitz F, Fareed J |
| |
|
Interaction of Beta2-Glycoprotein I with Members of the Low-density Lipoprotein Receptor (LDLR) Super Family
|
| Van Lummel M, Derksen RHWM, Westein E, Lenting PJ, De Groot PG |
| |
|
Interaction of Calmodulin with the Platelet ADP Receptor P2Y1
|
| Shen Y, Arthur J, Yip J, Aprico A, Leon C, Gachet C, Berndt M, Andrews R |
| |
|
Interaction of Choline/Betaine Metabolysm and Homocysteine Plasma Levels
|
| Gori AM, Sofi F, Fedi S, Bandinelli B, Attanasio M, Casini A, Surrenti C, Moneti G, Abbate R, Gensini GF |
| |
|
Interaction of CIB1 and GPIIb/IIIa Is Required for Activation of Src and FAK During Outside-In Signaling
|
| Naik MU, Naik UP |
| |
|
Interaction of Plasminogen and Angiostatin with Heat Shock Proteins
|
| Dudani A, Martyres A |
| |
|
Interaction of Selected Septin Proteins with Platelet Microtubules: Role in the Regulation of Platelet Exocytosis
|
| Martínez C, Corral J, Dent J, Rivera J, Vicente V, Ware J |
| |
|
Interactions between Prothrombotic Mutations and Hormone Therapy in Relation to the Risk of Venous Thromboembolism: Impact of the Route of Estrogen Administration
|
| Plu-Bureau G, Straczek C, Oger E, Conard J, Meyer G, Ahlenc-Gelas M, Lévesque H, Trillot N, Barellier MT, Wahl D, Scarabin PY |
| |
|
Interleukin 1 Haplotypes and the Risk of Venous Thrombosis
|
| van Minkelen R, de Visser MCH, Vos HL, Bertina RM, Rosendaal FR |
| |
|
Interleukin-10, Interleukin-6, and Interferon-g in Advanced Malignancy: Prognostic Relevance and Impact of Low-Molecular-Weight Heparin Administration
|
| Di Nisio M, Niers TM, Reitsma PH, Buller HR |
| |
|
Interleukin-18 Predicts Long-term Mortality in Patients with Non-ST Elevation Acute Coronary Syndrome
|
| Agneta S, Mälarstig A, Fläring A, Lagerqvist B, Lindahl B, Wallentin L |
| |
|
Interleukin-8 (IL-8) Generation in Whole Blood Is Related to Markers of Atherosclerosis
|
| Osterud B, Brox J, Breimo E, Eilertsen KE, Elvevoll EO, Lund T, Olsen JO |
| |
|
Interrelation Haemostasis and Intestinal Microbiota under Influence of Emotional Tension on Wistar Rats
|
| Botvinko IV, Kondashevskaya MV |
| |
|
Interstitial Pulmonary Lesions in Patients with Recurring Severe ITP
|
| Fontana V, Ahn Y, Donna E, Dudkiewicz P, Ahn E, Horstman L, Bidot C |
| |
|
Intersubject Variability in Intracellular and Surface Tissue Factor Distribution in LPS-Stimulated Monocytes
|
| Egorina E, Sovershaev M, Olsen JO, Bjørkøy G, Østerud B |
| |
|
Intervention of Plasminogen Activator Inhibitor-1 in Nasal Allergy
|
| Sejima T, Madoiwa S, Mimuro J, Sugo T, Ohmori T, Okada K, Ueshima S, Matsuo O, Ishida T, Ichimura K, Sakata Y |
| |
|
Intra-Articular Hylan GF 20 (Synvisc®) in the Treatment of Hemophilic Arthropathy
|
| Ashrani AA, Clohisy DR, Osip J, Christie BA, Key NS |
| |
|
Intracellular Assembly of Factor VIII and von Willebrand Factor
|
| van den Biggelaar M, Kootstra NA, Storm G, Mertens K |
| |
|
Intracellular PAR Antagonists Have Anticoagulant and Antithrombotic Properties
|
| Wielders S, Keuren J, Bennaghmouch A, Hackeng T, Deckmyn H, Bevers E, Lindhout T |
| |
|
Intracerabral Hematoma and Congenital Afibrinogenemia
|
| Pouzol P, Armari-Alla C, Gay V, Hanss M, de Mazancourt P, Pernod G, Barro C, Polack B |
| |
|
Intragenic and Extragenic Components Modulating Coagulation Factor VIII Levels and the Risk of Venous Thrombosis
|
| Lunghi B, Scanavini D, Marchetti G, Legnani C, Gatti S, Grassilli S, Coen M, Palareti G, Bernardi F |
| |
|
Intraoperative Automatic Autotransfusion for Lung Transplantation
|
| Quarentei RCA, Jatene FB, Cavalheiro Filho C, Rached RA, Caramori ML, Tavares ER, Chamone DAF |
| |
|
Intravenous DDAVP Associated Reduction in Fibrinogen – Implications for Patients with Von Willebrand's Disease or Haemophilia A with Borderline Fibrinogen Levels Requiring Invasive Procedures
|
| Needham J, Mainwaring CJ, Sood N, Stebbing Y, Schuster J, Lewis H, Knight S |
| |
|
Intravenous Leiomyosarcoma Presenting As Iliac Vein Thrombosis
|
| Evers EJ, Petermann C, Mall G, Huppert P, Naumann E, Bauersachs R |
| |
|
Intrinsic Factor Responsiveness of an aPTT Reagent Is Significantly Influenced by the Type of Factor Deficient Plasma Used
|
| Bethel M, Adcock DM, Ramanathan R |
| |
|
Introduction of Thromboelastography for Monitoring Haemostatic Function during Pseudomyxoma Peritonei Surgery
|
| Needham J, Mainwaring J, Roy A, Knight S, Lewis H, Davies J, Chandrakumaran K, Moran B |
| |
|
Investigating an Early Action Gene (6A3-5/hELD/OSA) in PDGF-Treated Human Airway Vascular Smooth Muscle Cells
|
| Morser Kira, Collot Sophie, Garin Gwen, Chun Fan, McGregor John, L |
| |
|
Investigation of Molecular Mechanisms Regulating Fibrinogen Secretion
|
| Vu D, Caille D, Di Sanza C, Scheib H, De Moerloose P, Meda P, Neerman-Arbez M |
| |
|
Investigation of Performance and Sample Interferences for a New Automated Protein S Functional Activity Assay (HemosIL ProS)
|
| Bottenus R, Vasquez J, Safa O, Preda L, Triscott M |
| |
|
Investigation of Relationship between ADAMTS-13, Von Willebrand Factor Antigen and Collagen-Binding Activity in Patients with Type 1 Von Willebrand Disease
|
| Millar CM, Starke R, Riddell AF, Griffioen A, Mackie I, Brown SA |
| |
|
Investigation of Relationship of von Willebrand Factor Antigen Clearance with ADAMTS-13 Activity and Tyr1584Cys Polymorphism in Type 1 von Willebrand Disease
|
| Millar CM, Starke R, Riddell AF, Griffioen A, Mackie I, Brown SA |
| |
|
Investigations of the Thrombin Generation Test in Patients with FV-L Mutation and Antiphospholipid Syndrome
|
| Peyvandi F, Miesbach W, Wegert W, Scharrer I |
| |
|
In-vitro Expression and Functional Characterization of Four Mutations Causing Factor XI Deficiency
|
| Duga S, Asselta R, Bozzao C, Ghiotto R, Malcovati M, Tenchini ML, Castaman G |
| |
|
In-vitro Reversal of Anticoagulant Effects of Specific Factor Xa and Thrombin Inhibitors
|
| Bretthauer N, Harenberg J, Giese, Ch, Fenyvesi T |
| |
|
Involvement of P2Y1 and P2Y12 Receptors in Platelet Responses to Adenosine Diphosphate and Thrombin Receptor Activating Peptide
|
| Manolopoulos P, Fox SC, Heptinstall S |
| |
|
Is it Possible to Predict the Degree of FVIII Deficiency from aPTT Waveform Analysis on Behring Coagulation Timer (BCT)
|
| Milos M, Coen Herak D, Zadro R |
| |
|
Is It Safe to Withhold Anticoagulant Therapy in Patients with Negative Results on Spiral CT Pulmonary Angiography?
|
| Girard P, Leroyer C, Parent F, Meyer G |
| |
|
Is Screening for Thrombophilia Mutations Necessary Prior to Free Functional Muscle Transfer?
|
| Vekris M, Ovrenovits M, Dova L, Beris A, Kolaitis N, Vartholomatos G |
| |
|
Is the Conversion of Single-chain to Two-chain Tissue Plasminogen Activator Part of a Deactivation Pathway Rather than Enzyme Activation
|
| Longstaff C, Thelwell C |
| |
|
Is the Maternal anti HPA-1a Antibody Concentration a Useful Parameter for Antenatal Management of High-risk Pregnancies?
|
| Gérald B, Vincent J, Cécile K |
| |
|
Is the Novel Genetic Mutation, Prothrombin C20209T, an Independent Risk Factor for Stroke among African-Americans with Sickle Cell Anemia?
|
| Itakura H, Telen MJ, Orringer EP, Eckman JR, Ashley-Koch A, White DA, Styles LA, Hoppe CC, Zehnder JL |
| |
|
Is the Rate of Clinical Manifestations of the Antiphospholipid Syndrome Associated to Cumulative Findings of Antiphospholipid Antibodies?
|
| Miesbach W, Asmelash G, Putz B, Matthias T, Scharrer I |
| |
|
Is There a Role of Thrombophilia in the Progression of Carotid Plaques and/or in the Onset of Cerebrovascular Ischemic Events in Asymptomatic Patients? Results of a Prospective Study (CAST Study)
|
| Camporese G, Franz F, Tormene D, Verlato F, Zerbinati P, Salmistraro G, Gavasso G, Pagnan A, Andreozzi GM, Simioni P |
| |
|
Ischemia/Reperfusion Induces the Binding of Circulated Immunoglobulins to Blood Vessels
|
| Bobrovnik S, Coutinho A |
| |
|
Ischemic Childhood Stroke and Lipoprotein (a)
|
| Lenicek Krleza J, Topic Zrinski R, Rogic D, Coen D, Duranovic V |
| |
|
Ischemic Complications in Nonvalvular Atrial Fibrillation Patients Despite Warfarin Therapy
|
| Poli D, Antonucci E, Cecchi E, Mannini L, Sestini I, Sticchi E, Falciani M, Abbate R, Gensini GF, Prisco D |
| |
|
Isolated Alpha-2 Antiplasmin Deficiency Presenting in a 63 year Old Man
|
| Harish VC, Lawson HL, Zhang L, Huff JD, Owen J |
| |
|
Isolation and Characterization of Human Bone-Derived Endothelial Cells (hBDECs) for the Study of Vascular Bone Disease States
|
| Kerachian MA, Harvey EJ, Cournoyer D, Chow T, Aird WC, Séguin C |
| |
|
Isolation of Megakaryocytic Cells over-Expressing TRPC Channels
|
| Ayman S, Snetkov V, Shaifta Y, Lavender P, Ward JPT, Authi KS |
| |
|
Isolation, Characterization and Angiogenic Potential of Human Mesenchymal Stem Cell-Derived Endothelial-Like Progenitor Cells
|
| Liu JW, Mai G, Fish R, Lambert J-F, Serre-Beinier V, Buehler L, Dunoyer-Geindre S, Bounameaux H, Kruithof EKO |
| |
|
Italian Experience in the Assessment of Performance of Clinical Laboratories for DNA Analyses to Detect Three Thrombophilic Mutations
|
| Chantarangkul V, Menegatti M, Tagliabue L, Peyvandi F, Tripodi A |
| |
|
ITP Developing in Spouses of Patients with Chronic ITP: ‘Spousal ITP’
|
| Ahn E, Jy W, Bidot C, Horstman L, Fontana V, Ahn Y |
| |
|
IVC Filters: Good or Bad; Anticoagulate or Not?
|
|
| |
